These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 3037300)

  • 21. The radiation chemistry of some platinum-containing radiosensitizers and related compounds.
    Butler J; Hoey BM; Swallow AJ
    Radiat Res; 1985 Apr; 102(1):1-13. PubMed ID: 4039071
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Nuclear and mitochondrial distribution of organoamidoplatinum(II) lesions in cisplatin-sensitive and -resistant adenocarcinoma cells.
    Talarico T; Cullinane CM; Gray PJ; Webster LK; Deacon GB; Phillips DR
    Anticancer Drug Des; 2001; 16(2-3):135-41. PubMed ID: 11962511
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Kinetics of DNA cross-linking in normal and neoplastic mouse tissues following treatment with cis-diamminedichloroplatinum(II) in vivo.
    Murray D; Jenkins WT; Meyn RE
    Cancer Res; 1985 Dec; 45(12 Pt 1):6446-52. PubMed ID: 4063992
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In vitro studies on mild alkali induced lesions in DNA.
    Musarrat J; Ahmad M
    Biochem Int; 1991 Sep; 25(2):249-59. PubMed ID: 1789792
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Role of carrier ligand in platinum resistance of human carcinoma cell lines.
    Schmidt W; Chaney SG
    Cancer Res; 1993 Feb; 53(4):799-805. PubMed ID: 8428361
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The formation of DNA interstrand cross-links by a novel bis-[Pt2Cl4(diminazene aceturate)2]Cl4.4H2O complex inhibits the B to Z transition.
    González VM; Fuertes MA; Jiménez-Ruíz A; Alonso C; Pérez JM
    Mol Pharmacol; 1999 Apr; 55(4):770-7. PubMed ID: 10101036
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Analysis of cytotoxicities of platinum compounds.
    Goodisman J; Hagrman D; Tacka KA; Souid AK
    Cancer Chemother Pharmacol; 2006 Jan; 57(2):257-67. PubMed ID: 16028101
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Flow cytometric evaluation of DNA digestion with S1 nuclease.
    Prosperi E; Bottiroli G; Supino R
    Basic Appl Histochem; 1987; 31(4):511-20. PubMed ID: 2831874
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antitumor activity of a new platinum(II) complex with low nephrotoxicity and genotoxicity.
    Marzano C; Bettio F; Baccichetti F; Trevisan A; Giovagnini L; Fregona D
    Chem Biol Interact; 2004 Jun; 148(1-2):37-48. PubMed ID: 15223355
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Detection of DNA single-strand breaks produced during the repair of damage by DNA-protein cross-linking agents.
    Fornace AJ
    Cancer Res; 1982 Jan; 42(1):145-9. PubMed ID: 7198506
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Arabinosyl-2-fluoroadenine augments cisplatin cytotoxicity and inhibits cisplatin-DNA cross-link repair.
    Yang LY; Li L; Keating MJ; Plunkett W
    Mol Pharmacol; 1995 May; 47(5):1072-9. PubMed ID: 7746274
    [TBL] [Abstract][Full Text] [Related]  

  • 32. DNA interactions of new antitumor platinum complexes with trans geometry activated by a 2-metylbutylamine or sec-butylamine ligand.
    Prokop R; Kasparkova J; Novakova O; Marini V; Pizarro AM; Navarro-Ranninger C; Brabec V
    Biochem Pharmacol; 2004 Mar; 67(6):1097-109. PubMed ID: 15006546
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A comparative study of the cytotoxicity and DNA-damaging effects of cis-(diammino)(1,1-cyclobutanedicarboxylato)-platinum(II) and cis-diamminedichloroplatinum(II) on L1210 cells.
    Micetich KC; Barnes D; Erickson LC
    Cancer Res; 1985 Sep; 45(9):4043-7. PubMed ID: 3896476
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Trans-diammineplatinum(II): what makes it different from cis-DDP? Coordination chemistry of a neglected relative of cisplatin and its interaction with nucleic acids.
    Lippert B
    Met Ions Biol Syst; 1996; 33():105-41. PubMed ID: 8742842
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of hyperthermia on the action of cis-diamminedichloroplatinum(II), rhodamine 123(2) [tetrachloroplatinum(II)], rhodamine 123, and potassium tetrachloroplatinate in vitro and in vivo.
    Herman TS; Teicher BA; Chan V; Collins LS; Kaufmann ME; Loh C
    Cancer Res; 1988 May; 48(9):2335-41. PubMed ID: 3356001
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Differential toxic effect of cis-platinum(II) and palladium(II) chlorides complexed with methyl 3,4-diamine-2,3,4,6-tetradeoxy-alpha-L-lyxo-hexopyranoside in mouse lymphoma cell lines differing in DSB and NER repair ability.
    Kruszewski M; Bouzyk E; Oldak T; Samochocka K; Fuks L; Lewandowski W; Fokt I; Priebe W
    Teratog Carcinog Mutagen; 2003; Suppl 1():1-11. PubMed ID: 12616592
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Detection of 5-bromo-2-deoxyuridine (BrdUrd) incorporation with monoclonal anti-BrdUrd antibody after deoxyribonuclease treatment.
    Takagi S; McFadden ML; Humphreys RE; Woda BA; Sairenji T
    Cytometry; 1993; 14(6):640-8. PubMed ID: 8404370
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Kinetic studies of the hydrolysis of platinum-DNA complexes by nuclease S1.
    Butour JL; Mazard AM; Vieussens C; Johnson NP
    Chem Biol Interact; 1990; 73(2-3):195-205. PubMed ID: 2311130
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Bleomycin-induced DNA lesions are dependent on nucleosome repeat length.
    Lönn U; Lönn S; Nylen U; Windblad G
    Biochem Pharmacol; 1990 Jan; 39(1):101-7. PubMed ID: 1688703
    [TBL] [Abstract][Full Text] [Related]  

  • 40. There exists a distinct stage during mammalian DNA synthesis immediately after joining of replication intermediates.
    Lönn U; Lönn S
    Nucleic Acids Res; 1986 May; 14(9):3883-94. PubMed ID: 3012484
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.